We would love to hear your thoughts about our site and services, please take our survey here.
Comparing APH with BXP, I personally think that BXP has greater potential for the share price to rise substantially due to its current very low PE-Ratio. APH is in my view fairly priced at region 40-50p. I welcome other views on this.
Alliance Pharma shares are no longer rising, currently a little out of favour.
Beximco Pharma shares are showing signs of rising, perhaps currently in favour.
I like APH, but I do not like the overhanging court case we hear nothing about.
On the Dhaka Stock Exchange, the price of BXP shares stands today at Taka 146.20 which translates into £1.05.
If our BXP-GDR shares we allowed to be traded on the Dhaka Stock Exchange the price would be in excess of £1.
Our Dividend Rights are precisely the same as those for the BXP shares traded on the Dhaka Stock Exchange.
Cheers to all who invest in our currently gravely underpriced BXP-GDR shares. I for one, have filled my boots.
The price of Beximco shares on the Dhaka Stock Exchange has remained unchanged for weeks at Taka 146.20 (=£1.05),
yet there are varying amounts of trades each day. I consider a stable share price as solid faith in the Company. Unlikely to go down, more likely to go up from that level. At £1.05 (translated price today) in Dhaka, our Beximco GDR shares here at 36.5p today, are at just one-third of the level in Bangladesh, yet our Dividends are precisely the same.
Make your own judgement...
(I happily own plenty, long term).
Jolly, pessimistic as ever. And what would you expect to happen after your imaginary ultra low target is reached? Would a rapid rise then follow? imagine a PE-ratio of 3 or 4 for a rapid growing Pharmaceutical Company. A chance to fill pockets and boots for exciting gains to follow…